Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orlistat plus phototherapy for neonatal jaundice
IRCT20190105042241N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of orlistat in jaundice (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Total serum bilirubin and Serum conjugated bilirubin. Started Feb 2019; status: completed.
02
Drugs
orlistat
03
Conditions
jaundice
Beyond the preview
Go deeper on IRCT20190105042241N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190105042241N1.